|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,542.50 GBX | +1.28% |
|
+2.12% | +14.67% |
| 01:30pm | Cerillion CEO seeks to sell GBP20 million in shares | AN |
| 12:52pm | BioNTech to acquire CureVac in $1.25 billion all-stock deal | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.28% | +2.12% | +10.33% | +3.62% | +14.67% | -3.80% | -28.87% | -22.76% | -10.04% | 83.58B | ||
| +0.46% | +5.58% | +10.08% | -1.87% | +4.74% | -6.61% | +172.25% | +461.22% | +833.84% | 726B | ||
| +0.59% | +1.33% | +0.67% | -6.39% | +7.36% | +5.79% | -10.02% | +10.22% | +56.45% | 374B | ||
| +0.16% | +5.94% | +17.69% | +2.34% | -16.77% | -47.50% | +34.90% | +140.45% | +173.49% | 353B | ||
| +0.50% | +2.22% | +3.74% | -10.34% | +7.77% | +14.19% | +33.73% | +107.57% | +181.45% | 338B | ||
| +0.17% | +1.12% | +3.36% | -11.91% | +5.95% | +11.17% | -12.47% | -16.87% | +0.74% | 264B | ||
| +0.40% | +0.74% | +6.23% | +1.12% | +9.80% | +2.88% | +17.65% | +21.34% | +3.22% | 232B | ||
| +0.40% | +2.43% | +6.70% | -5.92% | +4.70% | -12.08% | +12.10% | +33.64% | +160.27% | 229B | ||
| +0.31% | +2.62% | +5.73% | -15.21% | -19.26% | -39.08% | -7.87% | +3.84% | +36.34% | 202B | ||
| +0.59% | +1.67% | +9.76% | -8.49% | +11.96% | -2.96% | +21.58% | +33.31% | +84.74% | 157B | ||
| +0.84% | +4.66% | +9.87% | -5.81% | -7.73% | -12.67% | -51.01% | -26.49% | -28.96% | 139B | ||
| +0.70% | +0.26% | +12.79% | -4.48% | +18.33% | +68.44% | +79.95% | +50.05% | -8.25% | 136B | ||
| -0.31% | -1.20% | -5.16% | -18.41% | -7.79% | -3.20% | -9.84% | -2.90% | -3.09% | 121B | ||
| +0.33% | +1.48% | +6.46% | -7.35% | +12.35% | -6.04% | +77.51% | +71.45% | +258.08% | 116B | ||
| +0.36% | +4.61% | +7.99% | -18.45% | -11.32% | +16.60% | -33.20% | -11.55% | -23.83% | 102B | ||
| -1.13% | +2.96% | +3.35% | +8.81% | +7.86% | +52.01% | +112.41% | +39.41% | +480.69% | 86.86B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| -0.76% | -1.05% | +3.60% | +20.67% | +19.19% | +28.07% | +73.35% | -22.27% | +268.17% | 50.4B | ||
| -0.16% | -1.49% | -1.66% | +2.05% | +5.27% | +23.85% | - | - | - | 48.53B | ||
| +0.09% | +2.36% | +9.38% | -1.93% | +4.64% | +5.04% | +21.97% | +9.68% | -28.45% | 47.2B | ||
| Average | +0.20% | +2.37% | +6.36% | -4.10% | +3.77% | +4.95% | +28.01% | +48.85% | +135.27% | 193.48B | |
| Weighted average by Cap. | +0.32% | +3.17% | +7.20% | -5.08% | +2.60% | -1.83% | +45.42% | +119.64% | +234.85% |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition